Atsushi Takeda1,2, Takayuki Toda3, Takuma Fujii3, Noriaki Matsui3. 1. Kidney Center, Tsuchiura Kyodo General Hospital, Ibaraki, Japan. atakeda@midorino.com. 2. Midorino Clinic, 2526-1 Nishimura, Kutsukake, Bando, 306-0515, Japan. atakeda@midorino.com. 3. Kidney Center, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Abstract
BACKGROUND: Nondipper hypertensive patients have more pronounced target organ injury. We examined whether shifting the time of dosing long-acting antihypertensive drugs from morning to bedtime reduces nocturnal blood pressure (BP) and restores normal nocturnal dipping in nondippers with essential hypertension. METHODS: We studied 71 Japanese hypertensive patients who received long-acting antihypertensive drugs once daily in the morning using 24-h ambulatory BP monitoring. After determination of circadian BP pattern, medication time was changed to bedtime only in nondippers. RESULTS: Among 71 patients, 36 were classified as dippers and 35 as nondippers. After shifting administration time from morning to bedtime in 34 nondippers, the office and 24-h ambulatory BP did not change, but the diurnal BP slightly increased and nocturnal BP markedly decreased. The percentages of nocturnal decline in systolic and diastolic BP increased from 2.6% to 15.5% (P < 0.0001) and 5.6% to 16.9% (P < 0.0001). Morning BP at 7 a.m.-11 a.m. did not increase by bedtime administration. The frequency of dippers increased from 0/34 (0%) to 24/34 (71%). Adding to 50% of dippers on morning administration, 86% of the hypertensive patients became dippers by deciding the medication time according to dipper status. CONCLUSION: Nondippers on morning dosing can be changed to dippers by shifting administration time to bedtime, reducing nocturnal BP but not changing office BP, 24-h ambulatory BP or morning BP. In treating essential hypertensive patients, it is desirable to measure 24-h ambulatory BP as well as office BP and to decide the administration time of long-acting antihypertensive drugs to normalize nocturnal BP fall.
BACKGROUND: Nondipper hypertensivepatients have more pronounced target organ injury. We examined whether shifting the time of dosing long-acting antihypertensive drugs from morning to bedtime reduces nocturnal blood pressure (BP) and restores normal nocturnal dipping in nondippers with essential hypertension. METHODS: We studied 71 Japanese hypertensivepatients who received long-acting antihypertensive drugs once daily in the morning using 24-h ambulatory BP monitoring. After determination of circadian BP pattern, medication time was changed to bedtime only in nondippers. RESULTS: Among 71 patients, 36 were classified as dippers and 35 as nondippers. After shifting administration time from morning to bedtime in 34 nondippers, the office and 24-h ambulatory BP did not change, but the diurnal BP slightly increased and nocturnal BP markedly decreased. The percentages of nocturnal decline in systolic and diastolic BP increased from 2.6% to 15.5% (P < 0.0001) and 5.6% to 16.9% (P < 0.0001). Morning BP at 7 a.m.-11 a.m. did not increase by bedtime administration. The frequency of dippers increased from 0/34 (0%) to 24/34 (71%). Adding to 50% of dippers on morning administration, 86% of the hypertensivepatients became dippers by deciding the medication time according to dipper status. CONCLUSION: Nondippers on morning dosing can be changed to dippers by shifting administration time to bedtime, reducing nocturnal BP but not changing office BP, 24-h ambulatory BP or morning BP. In treating essential hypertensivepatients, it is desirable to measure 24-h ambulatory BP as well as office BP and to decide the administration time of long-acting antihypertensive drugs to normalize nocturnal BP fall.
Authors: J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster Journal: JAMA Date: 1999-08-11 Impact factor: 56.272
Authors: José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen Journal: Lancet Date: 2007-10-06 Impact factor: 79.321
Authors: Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Juan J Crespo; María T Ríos; Ana Moyá; Francesco Portaluppi Journal: Curr Hypertens Rep Date: 2014-02 Impact factor: 5.369
Authors: Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Francesco Portaluppi Journal: Hypertens Res Date: 2015-12-10 Impact factor: 3.872